semorinemab
Showing 1 - 2 of 2
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Terminated
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Birmingham, Alabama
- +132 more
Feb 16, 2022